| Jeffrey Michael Kuklinski, DO | |
|
1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 | |
| (610) 402-8111 | |
| (610) 402-1698 |
| Full Name | Jeffrey Michael Kuklinski |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1200 S Cedar Crest Blvd, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578507802 | NPI | - | NPPES |
| 101463298 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | OS012765 (Pennsylvania) | Primary |
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Leukotriene modifiers may provide a noninvasive treatment option for children with nonsevere obstructive sleep apnea, say researchers.
Using a microfluidic device designed to capture and enrich cells from biological samples, a research team at The University of Texas at Austin has developed a test that can detect an important early marker for oral squamous cell carcinoma, which accounts for more than 90 percent of oral cancers. Oral cancer is the sixth most common cancer worldwide and is difficult to detect early enough to treat successfully.
A doctor involved in a $7 million HIV infusion therapy scheme to defraud Medicare has been sentenced to 18 months in prison, seven months home confinement, and three years supervised release, Assistant Attorney General Alice S. Fisher of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of Florida announced today.
DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.
Wearing a lightweight vest equipped with a cardioverter defibrillator that detects abnormal heart rhythms in addition to taking recommended medications is associated with a reduction in the likelihood of dying during the first 90 days following a heart attack in people whose heart function was also impaired, according to a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Michael Kuklinski, DO Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Jeffrey Michael Kuklinski, DO 1200 S Cedar Crest Blvd, Allentown, PA 18103-6202 Ph: (610) 402-8111 |
News Archive
Leukotriene modifiers may provide a noninvasive treatment option for children with nonsevere obstructive sleep apnea, say researchers.
Using a microfluidic device designed to capture and enrich cells from biological samples, a research team at The University of Texas at Austin has developed a test that can detect an important early marker for oral squamous cell carcinoma, which accounts for more than 90 percent of oral cancers. Oral cancer is the sixth most common cancer worldwide and is difficult to detect early enough to treat successfully.
A doctor involved in a $7 million HIV infusion therapy scheme to defraud Medicare has been sentenced to 18 months in prison, seven months home confinement, and three years supervised release, Assistant Attorney General Alice S. Fisher of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of Florida announced today.
DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.
Wearing a lightweight vest equipped with a cardioverter defibrillator that detects abnormal heart rhythms in addition to taking recommended medications is associated with a reduction in the likelihood of dying during the first 90 days following a heart attack in people whose heart function was also impaired, according to a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
Alex Rosenau, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8111 | |
John Mccarthy, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8111 | |
David Eric Wiand, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1736 W Hamilton St, Allentown, PA 18104 Phone: 610-628-8384 | |
Dr. Susan K Yaeger, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-9750 Fax: 610-402-9763 | |
Dr. Jarod Berggren, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Tyler Frank Willing, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8111 | |
Sean Mcglinn, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1736 W Hamilton St, Allentown, PA 18104 Phone: 610-770-8379 |